PrEP Persistence Support and Monitoring in Areas of High HIV Burden in the Midwestern United States.


Journal

AIDS education and prevention : official publication of the International Society for AIDS Education
ISSN: 1943-2755
Titre abrégé: AIDS Educ Prev
Pays: United States
ID NLM: 9002873

Informations de publication

Date de publication:
06 2023
Historique:
medline: 10 7 2023
pubmed: 6 7 2023
entrez: 6 7 2023
Statut: ppublish

Résumé

Monitoring pre-exposure prophylaxis (PrEP) metrics can guide service delivery yet does not occur routinely. We developed a survey to understand current practices for monitoring PrEP at PrEP-providing organizations in Illinois and Missouri. The survey was distributed from September through November 2020; 26 organizations participated. Most respondents indicated ongoing efforts to screen for PrEP eligibility (66.7%), link to care (87.5%), and retain clients in care (70.8%); 70.8% reported collecting data on PrEP initiation, 41.7% on retention in care, and 37.5% on missed visits. Barriers to monitoring PrEP metrics included lack of IT support (69.6%), manual processes (69.6%), and lack of staff resources (65.2%). Most respondents offered clients support for PrEP retention and adherence and wanted to expand interventions for PrEP persistence, yet fewer monitored corresponding metrics. To enhance PrEP implementation, organizations should improve monitoring and evaluation of PrEP metrics along the entire continuum and respond with appropriate services to support clients.

Identifiants

pubmed: 37410372
doi: 10.1521/aeap.2023.35.3.235
pmc: PMC10328557
mid: NIHMS1911435
doi:

Substances chimiques

Anti-HIV Agents 0

Types de publication

Journal Article Research Support, N.I.H., Extramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

235-246

Subventions

Organisme : NIMH NIH HHS
ID : K23 MH118969
Pays : United States
Organisme : NIAID NIH HHS
ID : P30 AI117943
Pays : United States
Organisme : NIDA NIH HHS
ID : P30 DA027828
Pays : United States

Références

AIDS Patient Care STDS. 2022 Jun;36(6):236-248
pubmed: 35687813
MMWR Morb Mortal Wkly Rep. 2015 Nov 27;64(46):1291-5
pubmed: 26606148
Lancet HIV. 2020 Oct;7(10):e721-e730
pubmed: 32861269
Ann Epidemiol. 2018 Dec;28(12):841-849
pubmed: 29983236
Int J STD AIDS. 2019 Sep;30(10):978-984
pubmed: 31284842
N Engl J Med. 2011 Aug 11;365(6):493-505
pubmed: 21767103
AIDS. 2019 Nov 15;33(14):2189-2195
pubmed: 31436610
PLoS One. 2020 Oct 16;15(10):e0240745
pubmed: 33064763
PLoS One. 2017 Dec 27;12(12):e0189794
pubmed: 29281688
J Int AIDS Soc. 2016 Jun 13;19(1):20903
pubmed: 27302837
J Int AIDS Soc. 2019 Aug;22(8):e25370
pubmed: 31456348
N Engl J Med. 2010 Dec 30;363(27):2587-99
pubmed: 21091279
AIDS Care. 2021 Jun;33(6):697-705
pubmed: 32530302
Curr HIV/AIDS Rep. 2019 Feb;16(1):113-119
pubmed: 30701404
Lancet HIV. 2021 Feb;8(2):e114-e120
pubmed: 33128874
JAMA. 2019 Mar 5;321(9):844-845
pubmed: 30730529
Ann Epidemiol. 2018 Dec;28(12):850-857.e9
pubmed: 29941379
J Acquir Immune Defic Syndr. 2016 Dec 15;73(5):540-546
pubmed: 27851714
Curr HIV/AIDS Rep. 2020 Dec;17(6):643-653
pubmed: 32920764
AIDS. 2020 Oct 1;34(12):1801-1811
pubmed: 32558660
J Int AIDS Soc. 2019 Feb;22(2):e25252
pubmed: 30775846
MMWR Morb Mortal Wkly Rep. 2015 Nov 27;64(46):1296-301
pubmed: 26606257
Clin Infect Dis. 2020 Jul 27;71(3):583-585
pubmed: 31509603
AIDS Behav. 2018 Apr;22(4):1096-1099
pubmed: 29243109
Am J Prev Med. 2021 Nov;61(5 Suppl 1):S73-S86
pubmed: 34686294
Clin Infect Dis. 2018 Jul 2;67(2):283-287
pubmed: 29506057
PLoS One. 2020 Nov 5;15(11):e0241340
pubmed: 33151997
AIDS Behav. 2019 Oct;23(Suppl 3):296-303
pubmed: 31468296
Adm Policy Ment Health. 2011 Jan;38(1):4-23
pubmed: 21197565
AIDS Behav. 2018 Apr;22(4):1080-1095
pubmed: 29285638
AIDS. 2017 Mar 13;31(5):731-734
pubmed: 28060019
MMWR Morb Mortal Wkly Rep. 2018 Oct 19;67(41):1147-1150
pubmed: 30335734
AIDS Care. 2020 Dec;32(12):1581-1588
pubmed: 32338061
BMJ Open. 2022 May 11;12(5):e048478
pubmed: 35545381
AIDS. 2021 Nov 15;35(14):2375-2381
pubmed: 34723852
Clin Infect Dis. 2015 Nov 15;61(10):1590-7
pubmed: 26270691
Patient Prefer Adherence. 2021 Feb 05;15:259-269
pubmed: 33574659
Implement Sci. 2015 Feb 12;10:21
pubmed: 25889199
Ann Epidemiol. 2018 Dec;28(12):833-840
pubmed: 30037634
AIDS Behav. 2020 Sep;24(9):2509-2519
pubmed: 32048078
AIDS. 2020 Nov 1;34(13):1951-1957
pubmed: 33009011
J Int Assoc Provid AIDS Care. 2016 Nov;15(6):522-528
pubmed: 27502831
AIDS. 2016 Jul 31;30(12):1973-83
pubmed: 27149090
AIDS Behav. 2018 Nov;22(11):3566-3575
pubmed: 29404756
J Med Internet Res. 2020 Oct 23;22(10):e23173
pubmed: 33095177

Auteurs

Moira C McNulty (MC)

Department of Medicine, Section of Infectious Diseases and Global Health, University of Chicago, Chicago, Illinois.
Chicago Center for HIV Elimination, University of Chicago, Chicago, Illinois.

Jared Kerman (J)

Department of Medicine, Section of Infectious Diseases and Global Health, University of Chicago, Chicago, Illinois.
Chicago Center for HIV Elimination, University of Chicago, Chicago, Illinois.

Samantha A Devlin (SA)

Department of Medicine, Section of Infectious Diseases and Global Health, University of Chicago, Chicago, Illinois.
Chicago Center for HIV Elimination, University of Chicago, Chicago, Illinois.

Maria Pyra (M)

Department of Medicine, Section of Infectious Diseases and Global Health, University of Chicago, Chicago, Illinois.
Chicago Center for HIV Elimination, University of Chicago, Chicago, Illinois.
Howard Brown Health, Chicago, Illinois.
Department of Medical Social Science, Northwestern University Feinberg School of Medicine, Chicago, Illinois.

Laura Rusie (L)

Howard Brown Health, Chicago, Illinois.

Kate Curoe (K)

Division of Infectious Diseases, Department of Internal Medicine, Washington University School of Medicine, St. Louis, Missouri.

Liz Thompson (L)

Howard Brown Health, Chicago, Illinois.
City Colleges of Chicago-Malcolm X College.

Joseph A Mason (JA)

Department of Medicine, Section of Infectious Diseases and Global Health, University of Chicago, Chicago, Illinois.
Chicago Center for HIV Elimination, University of Chicago, Chicago, Illinois.

Eleanor E Friedman (EE)

Department of Medicine, Section of Infectious Diseases and Global Health, University of Chicago, Chicago, Illinois.
Chicago Center for HIV Elimination, University of Chicago, Chicago, Illinois.

A Ziggy Uvin (AZ)

Department of Medicine, Section of Infectious Diseases and Global Health, University of Chicago, Chicago, Illinois.
Chicago Center for HIV Elimination, University of Chicago, Chicago, Illinois.
Boston University School of Medicine.

C Hendricks Brown (CH)

Center for Prevention Implementation Methodology, Northwestern University, Chicago, Illinois.

John Schneider (J)

Department of Medicine, Section of Infectious Diseases and Global Health, University of Chicago, Chicago, Illinois.
Chicago Center for HIV Elimination, University of Chicago, Chicago, Illinois.

Rupa Patel (R)

Division of Infectious Diseases, Department of Internal Medicine, Washington University School of Medicine, St. Louis, Missouri.
Whitman-Walker Health, Washington, D.C.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH